WSL Future of Health Event

AllianceRx Walgreens Prime

AllianceRx Walgreens Prime announces research results

AllianceRx Walgreens Prime announces research results

ORLANDO, Fla. — AllianceRx Walgreens Prime and Walgreens recently announced results from separate research studies exploring the impact of adherence on hospitalizations and medical costs as they related to cystic fibrosis (CF) and ulcerative colitis (UC)/Crohn’s disease, respectively. Researchers wanted to better understand the effect of adherence on patient outcomes and well-being. Findings from both

AllianceRx Walgreens Prime, Highmark launch health pilot

AllianceRx Walgreens Prime, Highmark launch health pilot

ORLANDO, Fla. — Helping improve patient outcomes by identifying and removing barriers to their care is just one reason AllianceRx Walgreens Prime and Highmark Inc. said they have joined forces to launch a social determinants of health (SDOH) pilot outreach program. The pilot will kick off with Highmark insurance members who have a multiple sclerosis (MS) diagnosis and use

Walgreens, Prime Therapeutics launch company

Walgreens, Prime Therapeutics launch company

DEERFIELD, Ill. — Walgreens and pharmacy benefit manager Prime Therapeutics LLC have completed their transaction to form a joint pharmacy services company and announced its leadership. Called AllianceRx Walgreens Prime and based in Orlando, Fla., the new company melds the central specialty pharmacy and mail service businesses of Walgreens and Prime Therapeutics, which is owned